Concepedia
Statistics
Publications
1
Citations
132
H-Index
Active since
2011
K. B. Kim is an author specializing in targeted therapy, oncology, and neoplasia.
Publications per year
2011–2011
BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with <i>BRAF</i> V600E mutation-positive metastatic melanoma.
A. Ribas, K. B. Kim, Lynn M. Schuchter et al. · Journal of Clinical Oncology · 2011 · 132 citations
Medicine, Oncology, Pharmacology +14
1–1 of 1